Personalized Motor Learning in Primary Care Physiotherapy (TREAT)

Personalized Motor Learning in Primary Care Physiotherapy; A Prospective Formative Process Evaluation

Over the last decade many scientific articles have been published on motor learning in neurological and geriatric rehabilitation. To make the available findings comprehendible and clear for physiotherapists, a card set and website have been developed.

The aim of this prospective study is to evaluate the use and experiences of the card set and website designed to aid the physiotherapist in decision making with regards to motor learning. The following research question is central to this evaluation: How are the developed card set and website used and experienced by physiotherapists in primary care during the treatment of patients with neurological or geriatric conditions?

Study Overview

• Status: Completed
• Conditions: Neurological Disorder; Geriatric Patients

Detailed Description

Method: Formative process evaluation.

Over the last decade many scientific articles have been published on motor learning in neurological and geriatric rehabilitation. To make the available findings comprehendible and clear for physiotherapists, a card set and website have been developed. Participating physiotherapists will use the "card set and website" in their daily practice for a period of six months. To assess the usage and experiences of therapists, digital questionnaires will be administered prior to the intervention, at 3 months, and at 6 months, along with bi-weekly monitoring. The quantitative data from the questionnaires and monitoring will be analyzed using descriptive statistics (e.g., frequency tables, means, medians, IQR, and summary figures). Additionally, an interim evaluation will take place where solutions for the main user issues will be collectively brainstormed with the participants. Finally, a consensus meeting will be held to reach the final versions of the card set and website. The nominal group technique will be used to ensure active participation from all participants and to achieve consensus on the definitive list of modifications.

• Study Type: Observational
• Enrollment (Actual): 10

Contacts and Locations

Study Locations

• Netherlands
  • Limburg
    • Heerlen, Limburg, Netherlands, 6419 DJ
      • Zuyd University of Applied Sciences

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Child; Adult; Older Adult
• Accepts Healthy Volunteers: Yes

• Sampling Method: Non-Probability Sample

Study Population

Healthy working physiotherapist will be included for this study to help evaluate the card set and website

Description

Physiotherapists will be eligible for inclusion when they:

• have at least one year of working experience
• are treating neurological and/or geriatric patients
• are able to attend the preparatory training provided by the researchers

Study Plan

How is the study designed?

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Questionnaire	A qualitative questionnaire will be filled in three times throughout the study. This questionnaire inquires participants' experience regarding the card set and website.	Six months
Monitor	A quantitative questionnaire will be filled in biweekly. This questionnaire assesses the frequency of usage of the card set and website	Six months
Midterm evaluation	This meeting will be held to further specify and solve user problems. During this in-person session, problems that arise during the usage of the material will be discussed in depth under supervision from an experienced researcher. The meeting will be audio recorded whereafter it will be transcribed and analyzed into clusters and themes.	At three months into the study
Consensus meeting	The goal of this meeting is to reach a final version of the card set and website based on the experiences from the process evaluation. During the in-person session, a nominal group method will ensure consensus regarding possible changes to the material and future directions the material should take e.g., more emphasis on the analogue or digital component or implementation into education. Through communal voting participants will make decisions regarding possible solutions or directions of the material. The session will be audio recorded and transcribed for analysis.	At six months into the study

Collaborators and Investigators

• Sponsor: Zuyd University of Applied Sciences
• Collaborators: Brunel University London; Maastricht Universitair Medisch Centrum; Fysio Bunde; Fysio Regtop; Fysiotherapie zesgehuchten; Fysiotherapie Veldhoven zuyd; Fysiotherapie ART-health; Fysio van het Hoof; Fysiotherapie Corine Cuijpers; Frank Helgers; Fysiotherapie Kemps-Rijf; Cerfontaine&vanderLoop; Fysiotherapie Denssana; Regieorgaan SIA; Fontys Paramedische Hogeschool; Kennisnetwerk CVA Nederland; Koninklijk Nederlands Genootschap voor Fysiotherapie (KNGF)
• Investigators: Principal Investigator: Li-Juan Jie, PhD, Zuyd University of Applied Sciences; Principal Investigator: Guus Rothuizen, MSc, Zuyd University of Applied Sciences

Publications and helpful links

General Publications

• Kleynen M, Beurskens A, Olijve H, Kamphuis J, Braun S. Application of motor learning in neurorehabilitation: a framework for health-care professionals. Physiother Theory Pract. 2020 Jan;36(1):1-20. doi: 10.1080/09593985.2018.1483987. Epub 2018 Jun 19.

Helpful Links

• The developed website to be evaluated in this project

Study record dates

Study Major Dates

• Study Start (Actual): September 6, 2023
• Primary Completion (Actual): February 26, 2024
• Study Completion (Actual): March 15, 2024

Study Registration Dates

• First Submitted: September 13, 2023
• First Submitted That Met QC Criteria: April 24, 2024
• First Posted (Actual): April 30, 2024

Study Record Updates

• Last Update Posted (Actual): April 30, 2024
• Last Update Submitted That Met QC Criteria: April 24, 2024
• Last Verified: April 1, 2024

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Nervous System Diseases
• Other Study ID Numbers: METCZ20230061

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No